Monoclonal antibody-based therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monoclonal antibody-based therapy, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma [Phase 2]